These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35663751)

  • 81. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Construction of a prognostic model for lung squamous cell carcinoma based on seven N6-methylandenosine-related autophagy genes.
    Yu X; Liu J; Xie R; Chang M; Xu B; Zhu Y; Xie Y; Yang S
    Math Biosci Eng; 2021 Aug; 18(5):6709-6723. PubMed ID: 34517553
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
    Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
    BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Comprehensive analysis of molecular features, prognostic values, and immune landscape association of m6A-regulated immune-related lncRNAs in smoking-associated lung squamous cell carcinoma.
    Zhang M; Zhang J; Liu Y
    Front Genet; 2022; 13():887477. PubMed ID: 36035178
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma.
    Yin Z; Zhou M; Liao T; Xu J; Fan J; Deng J; Jin Y
    Front Oncol; 2021; 11():673567. PubMed ID: 35083132
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
    Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F
    J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954
    [TBL] [Abstract][Full Text] [Related]  

  • 87. An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis.
    Wang X; Gao M; Ye J; Jiang Q; Yang Q; Zhang C; Wang S; Zhang J; Wang L; Wu J; Zhan H; Hou X; Han D; Zhao S
    Front Genet; 2020; 11():612037. PubMed ID: 33391355
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma.
    Tian Y; Yu M; Sun L; Liu L; Wang J; Hui K; Nan Q; Nie X; Ren Y; Ren X
    J Comput Biol; 2020 Jul; 27(7):1067-1078. PubMed ID: 31750732
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status.
    Chen C; Wu Y; Chen K; Xia Z; Liu X; Zhang C; Zhao H; Shen A
    Front Genet; 2022; 13():898507. PubMed ID: 35754846
    [No Abstract]   [Full Text] [Related]  

  • 90. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
    Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
    World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
    Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
    J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Transcriptome analysis of distinct long non-coding RNA transcriptional fingerprints in lung adenocarcinoma and squamous cell carcinoma.
    Wei Y; Zhang X
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27797003
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Prognostic Value of Genomic Instability of m
    Li R; Li JP; Liu TT; Huo C; Yao J; Ji XL; Qu YQ
    Front Cell Dev Biol; 2022; 10():707405. PubMed ID: 35309906
    [No Abstract]   [Full Text] [Related]  

  • 94. Identification of Tumor Microenvironment-Related Prognostic lncRNAs in Lung Adenocarcinoma.
    Yuan L; Li F; Wang S; Yi H; Li F; Mao Y
    Front Oncol; 2021; 11():719812. PubMed ID: 34408984
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Identification of Iron Metabolism-Related Genes as Prognostic Indicators for Lower-Grade Glioma.
    Xu S; Wang Z; Ye J; Mei S; Zhang J
    Front Oncol; 2021; 11():729103. PubMed ID: 34568059
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A Seven Immune-Related lncRNAs Model to Increase the Predicted Value of Lung Adenocarcinoma.
    Li JP; Li R; Liu X; Huo C; Liu TT; Yao J; Qu YQ
    Front Oncol; 2020; 10():560779. PubMed ID: 33163400
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J; Lin X; Zhuang J; He F
    Front Genet; 2021; 12():714697. PubMed ID: 34777460
    [No Abstract]   [Full Text] [Related]  

  • 98. Identification and Validation of an EMT-Related LncRNA Signature for HNSCC to Predict Survival and Immune Landscapes.
    Feng C; Liu S; Shang Z
    Front Cell Dev Biol; 2021; 9():798898. PubMed ID: 35273966
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Identification and Validation of an Autophagy-Related lncRNA Signature for Patients With Breast Cancer.
    Zhang R; Zhu Q; Yin D; Yang Z; Guo J; Zhang J; Zhou Y; Yu JJ
    Front Oncol; 2020; 10():597569. PubMed ID: 33614483
    [TBL] [Abstract][Full Text] [Related]  

  • 100. An Immune-Related lncRNA Expression Profile to Improve Prognosis Prediction for Lung Adenocarcinoma: From Bioinformatics to Clinical Word.
    Zhang B; Wang R; Li K; Peng Z; Liu D; Zhang Y; Zhou L
    Front Oncol; 2021; 11():671341. PubMed ID: 33968781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.